-
July 13: The Week in Cancer NewsAn opinion piece discusses how the stigma surrounding opioids affects cancer patients, and a study provides data on treating melanoma patients with brain metastases.
by Kate Yandell
-
July 6: The Week in Cancer NewsStudies explore what type of cervical cancer screening is most effective and whether patients with autoimmune diseases can take immunotherapy.
by Kate Yandell
-
June 29: The Week in Cancer NewsStudies explore occupational hazards that could increase cancer risk, and the U.S. Food and Drug Administration approves a new combination therapy for melanoma.
by Kate Yandell
-
June 22: The Week in Cancer NewsExperts debate direct-to-consumer genetic testing and studies shed light on breast reconstruction complications.
by Kate Yandell
-
AACR Annual Meeting 2018A roundup of news from the American Association for Cancer Research Annual Meeting 2018.
-
Making Sense of Cancer ProgressCancer Today editor Kevin McLaughlin contemplates what it means to report on cancer research advances when so many continue to die of the disease.
by Kevin McLaughlin
-
A Book Club for Cancer Survivors and CaregiversShare your experiences as we discuss “A Cure Within” in a Cancer Today Facebook group.
by Marci A. Landsmann
-
Welcome to Our New WebsiteAn updated site and a new digital editor means better and faster cancer coverage for our readers.
by Cancer Today Staff
-
Integrative Strategies for Facing Cancer
Brain tumor survivor uses her experiences to help others.
by Jeannine Walston
Alfred Lacks Carter Jr. and other family members honor the legacy of Henrietta Lacks by helping others better understand their health care.
by Kevin McLaughlin
Researchers Tackle Immune-related Adverse EffectsScientists present data on the risks of immune checkpoint inhibitors so more patients can tap into the treatment.
by Marci A. Landsmann
Tissue and Liquid Biopsy for Targeted TherapyTailored treatments led to better outcomes than standard of care when biomarker results from liquid biopsy and tumor tissue aligned.
by Eric Fitzsimmons
Cancer Vaccines Show Promise in Early TrialsWhile mRNA vaccines offer a personalized approach to triggering an immune response, peptide vaccines could be a one-size-fits-all treatment. Researchers are exploring both options.
by Thomas Celona
-
Inaugural AACR IO Conference Kicks Off With Celebration of Immune CheckpointsImmune checkpoint icons James Allison and Arlene Sharpe shared their journeys and a look ahead on the opening night of the inaugural AACR IO conference.
-
A New Resource Provides a Sanctuary for Black TNBC PatientsThe Black TNBC Sanctuary was created to help Black women with triple-negative breast cancer get answers about their diagnosis and care.
Dr. Humberto M. Guiot: Targeting Pancreatic Cancer in a Community-Based Clinical Trial
